|
|
||||||||
Impairs Insulin-Like Growth Factor I-Induced Differentiation and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts1



* Laboratories of Immunophysiology,
Developmental Endocrinology, and
Integrative Biology, Department of Animal Sciences, University of Illinois, Urbana-Champaign, Urbana, IL 61801; and
Integrative Neurobiology, FRE, Centre National de la Recherche Scientifique, Unité Mixte de Recherche Institut National de la Recherche Agronomique, Institut François Magendie des Neurosciences, Bordeaux, France
Proinflammatory cytokines are elevated in disorders characterized by muscle wasting and weakness, such as inflammatory myopathies and AIDS wasting. We recently demonstrated that TNF-
impairs the ability of insulin-like growth factor (IGF)-I to promote protein synthesis in muscle precursor cells. In this study we extend these findings by showing that low concentrations of IL-1
impair IGF-I-dependent differentiation of myoblasts, as assessed by expression of the muscle specific protein, myosin heavy chain. In the absence of exogenous IGF-I, IL-1
(1 ng/ml) did not impair muscle cell development. However, in the presence of IGF-I, 100-fold lower concentrations of IL-1
(0.01 ng/ml) significantly suppressed myoblast differentiation, protein synthesis, and myogenin expression. Increasing IL-1
to 1 ng/ml completely blocked the anabolic actions of IGF-I in murine C2C12 myoblasts. Similarly, IL-1
inhibited IGF-I-stimulated protein synthesis in primary porcine myoblasts. IL-1
impaired the actions of IGF-I at a point distal to the IGF receptor, and this was not due to IL-1
-induced cell death. Instead, IL-1
inhibited the ability of IGF-I to phosphorylate tyrosine residues on both of its downstream docking proteins, insulin receptor substrate 1 and insulin receptor substrate 2. These data establish that physiological concentrations of IL-1
block the ability of IGF-I to promote protein synthesis, leading to reduced expression of the myogenic transcription factor, myogenin, and the subsequent development of more mature differentiated cells that express myosin heavy chain. Collectively, the results are consistent with the notion that very low concentrations of IL-1
significantly impair myogenesis, but they are unable to do so in the absence of the growth factor IGF-I.
This article has been cited by other articles:
![]() |
J. Petremand, N. Bulat, A.-C. Butty, C. Poussin, S. Rutti, K. Au, S. Ghosh, V. Mooser, B. Thorens, J.-Y. Yang, et al. Involvement of 4E-BP1 in the Protection Induced by HDLs on Pancreatic {beta}-Cells Mol. Endocrinol., October 1, 2009; 23(10): 1572 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, J. S. Moylan, M. A. Chambers, J. Smith, and M. B. Reid Interleukin-1 stimulates catabolism in C2C12 myotubes Am J Physiol Cell Physiol, January 1, 2009; 297(3): C706 - C714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmidt, K. Barthel, A. Wrede, M. Salajegheh, M. Bahr, and M. C. Dalakas Interrelation of inflammation and APP in sIBM: IL-1{beta} induces accumulation of {beta}-amyloid in skeletal muscle Brain, May 1, 2008; 131(5): 1228 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Strle, R. H. McCusker, R. W. Johnson, S. M. Zunich, R. Dantzer, and K. W. Kelley Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1{beta} Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E709 - E718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Carroll Bidirectional communication: Growth and immunity in domestic livestock J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dogra, H. Changotra, N. Wedhas, X. Qin, J. E. Wergedal, and A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J, June 1, 2007; 21(8): 1857 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis J. Exp. Med., May 14, 2007; 204(5): 1057 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Strle, S. R. Broussard, R. H. McCusker, W.-H. Shen, J. M. LeCleir, R. W. Johnson, G. G. Freund, R. Dantzer, and K. W. Kelley C-Jun N-Terminal Kinase Mediates Tumor Necrosis Factor-{alpha} Suppression of Differentiation in Myoblasts Endocrinology, September 1, 2006; 147(9): 4363 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Berkley, S. S. Zalcman, and V. R. Simon Sex and gender differences in pain and inflammation: a rapidly maturing field Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R241 - R244. [Full Text] [PDF] |
||||
![]() |
V E MacRae, C Farquharson, and S F Ahmed The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J. Endocrinol., May 1, 2006; 189(2): 319 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. MacRae, C. Farquharson, and S. F. Ahmed The pathophysiology of the growth plate in juvenile idiopathic arthritis Rheumatology, January 1, 2006; 45(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Strle, S. R. Broussard, R. H. McCusker, W.-H. Shen, R. W. Johnson, G. G. Freund, R. Dantzer, and K. W. Kelley Proinflammatory Cytokine Impairment of Insulin-Like Growth Factor I-Induced Protein Synthesis in Skeletal Muscle Myoblasts Requires Ceramide Endocrinology, October 1, 2004; 145(10): 4592 - 4602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |